Insights into the impact of microbiota in the treatment of NAFLD/NASH and its potential as a biomarker for prognosis and diagnosis
16 CagriSema (semaglutide + cagrilintide) CagriSema integrates a once-weekly injection of semaglutide (2.4 mg) and cagrilintide (2.4 mg)
Circulating microbial metabolites and immune mediators can access systemic circulation and interact with the bloodbrain barrier (BBB), endothelial cells, and resident immune cells
A balanced diet with fiber-rich foods (fruits, vegetables, whole grains), lean proteins (chicken, fish, tofu), healthy fats (avocados, nuts, olive oil), and low in processed sugars works best with dietary supplements for maximum effectiveness
While initial studies indicate it may offer superior weight loss benefits, the long-term safety data are still developing